Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Dec 01, 2016, 08:05 ET Aytu BioScience to Present at 9th Annual LD Micro Investor Conference

Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of...


Dec 01, 2016, 08:03 ET Akashi Therapeutics Appoints Alka Batycky to Executive Vice-President, Portfolio Management and Operations

Akashi Therapeutics, a clinical stage biopharmaceutical company, announced the appointment of Alka Batycky, PhD as executive vice president,...


Dec 01, 2016, 08:00 ET U.S. FDA Grants Fast Track Designation for HER2-Targeting Antibody Drug Conjugate DS-8201 for HER2-Positive Metastatic Breast Cancer

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...


Dec 01, 2016, 08:00 ET MilliporeSigma Expands Distribution Agreement with Roche in Canada

-- MilliporeSigma to be the exclusive supplier of novel enzymes for polymerase chain reaction (PCR) and quantitative real-time PCR, for all...


Dec 01, 2016, 08:00 ET Xencor, Inc. Prices Public Offering of Common Stock

Xencor, Inc. (NASDAQ: XNCR) today announced the pricing of an underwritten public offering of 4,585,000 shares of its common stock, offered at a...


Dec 01, 2016, 08:00 ET Omnicell Showcases Expanded Portfolio of Award-Winning Medication Management Solutions at Annual ASHP Midyear Meeting

Omnicell, Inc., (NASDAQ: OMCL) a leading provider of medication and supply management solutions and adherence tools for healthcare systems and...


Dec 01, 2016, 08:00 ET Roche expands distribution alliance with the life science business of Merck KGaA, Darmstadt, Germany to include Kapa Biosystems qPCR and endpoint PCR Portfolios

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an expansion of their distribution alliance with the life science business of Merck KGaA,...


Dec 01, 2016, 08:00 ET IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

ARMONK, N.Y. and NEW YORK, Dec. 1, 2016 /PRNewswire/ -- IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) today announced a collaboration...


Dec 01, 2016, 07:30 ET Avelas Announces AVB-620 Presentation at 2016 San Antonio Breast Cancer Symposium

Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through...


Dec 01, 2016, 07:10 ET Technical Reports on Generic Drugs Stocks -- Mylan, Horizon Pharma, Allergan, and Catalent

Pre-market, Stock-Callers.com brings focus back on the global Generic Drugs industry, which, as per market research firm - Technavio, is...


Dec 01, 2016, 07:00 ET GenVec Effects 1-for-10 Reverse Stock Split

GenVec, Inc. (NASDAQ: GNVC) ("GenVec" or "the Company") announced that the Company's previously declared one-for-ten reverse stock split of its...


Dec 01, 2016, 07:00 ET NanoViricides Publishes a Letter from the CEO to Shareholders on its Website

NanoViricides, Inc. (NYSE MKT: NNVC), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines...


Dec 01, 2016, 07:00 ET Synthetic Biologics Announces Participation in Two Upcoming Investor Conferences

Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome, today announced...


Dec 01, 2016, 06:23 ET Indegene Acquires US-based Encima Group to Strengthen Omnichannel Analytics Capabilities

Indegene (http://www.indegene.com), a global healthcare solutions provider, today announced the acquisition of The Encima Group - a pioneer in...


Dec 01, 2016, 03:00 ET PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 in CD13-Expressing Tumor-Cells

PharmaMar (MCE: PHM), a world leader in the discovery, development and commercialization of new antitumor compounds of a marine origin, has...


Dec 01, 2016, 03:00 ET PharmaMar presenta risultati positivi con il suo anticorpo coniugato MI130110 nelle cellule tumorali che esprimono CD13

PharmaMar (MCE: PHM), società leader mondiale nella scoperta, nello sviluppo e nella commercializzazione di nuovi composti antitumorali di...


Dec 01, 2016, 03:00 ET PharmaMar präsentiert positive Ergebnisse für seine konjugierten Antikörper MI130110 bei CD13-exprimierenden Tumorzellen

PharmaMar (MCE: PHM), ein weltweit führendes Unternehmen bei der Entdeckung, Entwicklung und Vermarktung neuer Antitumor-Verbindungen marinen...


Dec 01, 2016, 03:00 ET PharmaMar présente des résultats positifs avec son anticorps conjugué MI130110 dans les cellules tumorales exprimant l'antigène CD13

PharmaMar (MCE : PHM), un leader mondial en matière de découverte, de développement et de commercialisation de nouveaux composés antitumoraux...


Dec 01, 2016, 00:00 ET Secondary Endpoint Data for S-033188, a Novel Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza, Support Favorable Primary Endpoint Data Previously Released

Shionogi & Co., Ltd. (hereafter "Shionogi") presented additional clinical data from a Phase 2 proof-of-concept study for S-033188, a...


Nov 30, 2016, 21:06 ET Global Market Study on Vitamin Supplements: Vitamin D Segment to Witness Highest Growth by 2020

With increasing age, it is difficult for the body to optimally absorb the required nutrients from food. Furthermore, loss of appetite is also a...


Nov 30, 2016, 19:07 ET Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

"Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations" is a comprehensive report on...


Nov 30, 2016, 18:31 ET The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure

Amgen (NASDAQ:AMGN) and Cytokinetics, Inc. (NASDAQ:CYTK) today announced The Lancet published results from a Phase 2 clinical trial evaluating...


Nov 30, 2016, 18:01 ET Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


Nov 30, 2016, 18:01 ET Los pacientes con una forma avanzada de cáncer de tiroides podrán beneficiarse a partir de ahora del tratamiento con Lenvima® (lenvatinib) en España

Los pacientes con carcinoma diferenciado de tiroides refractario al yodo radioactivo (CDT-RYR) en España tendrán ahora acceso a Lenvima®...


Nov 30, 2016, 17:08 ET PDA Quality Metrics Task Force to Comment on U.S. FDA Metrics Draft Guidance

The Parenteral Drug Association (PDA) is preparing comments on the U.S. FDA's revised draft guidance for industry: Submission of Quality Metrics...